With the rapid development of global medicine technology， China's biornedicine industry has entered a crucial stage of transformation， upgrading， and high-quality development. The "Opinions on Comprehensively Deepening Drug and Medical Device Regulatory Reforms to Promote High-Quality Development of the Pharmaceutical Industry" issued by the General Office of the State Council provides strong momentum for achieving high-quality industry development. Guided by the concept of new quality productive forces， these reforms comprehensively deepen regulatory improvements for drugs and medical devices， optimize review and approval processes， and enhance regulatory efficiency， which aim to meet people's higer aspirations for health and well-being. This article provides an in-depth analysis of the specific contents and implications of the "Opinions on Comprehensively Deepening Drug and Medical Device Regulatory Reforms to Promote High-Quality Development of the Pharmaceutical Industry" from the perspective of the medical device industry， explores how these reform measures can foster innovation and development in the medical device industry， improve the safety and efficacy of products， and strengthen corporate compliance awareness and social responsibility.